• Mashup Score: 1

    David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, shares the highlights from the immunotherapy session at iwCLL…

    Tweet Tweets with this article
    • David Maloney of @fredhutch discusses pros and cons of allo-SCT and CAR-T therapies for chronic lymphocytic #Leukemia. ➡️Watch here: https://t.co/Smssm5lNAH @iwCLL #iwCLL2021 #CLLsm #LEUsm #ImmunoOnc #CART #BMTsm #HemOnc

  • Mashup Score: 8

    Zack Pemberton-Whiteley, Leukemia Care, Worcester, UK, discusses the findings of a study investigating the experiences of patients with chronic lymphocytic…

    Tweet Tweets with this article
    • Zack Pemberton-Whiteley (@ZPWLC) of @LeukaemiaCareUK shares experiences of patients with chronic lymphocytic #Leukemia during the #COVID19 pandemic. ▶️Watch here: https://t.co/9JmyuLimTs @iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc

  • Mashup Score: 0

    Lydia Scarfò, MD, Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, Milan, Italy, discusses the challenges of selecting…

    Tweet Tweets with this article
    • Lydia Scarfò of @MyUniSR discusses the optimal frontline treatment options for patients with chronic lymphocytic #Leukemia. ➡️Watch here: https://t.co/za0YBCML5A⬅️ @iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc

  • Mashup Score: 0

    Dimitar Efremov, MD, PhD, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy, discusses the role of different receptor-ligand systems…

    Tweet Tweets with this article
    • Dimitar Efremov of @ICGEB comments on new findings on BCL and CXCR4 receptors for cell migration in chronic lymphocytic #Leukemia. 👉Watch here: https://t.co/mdqP9j0mVe @iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc

  • Mashup Score: 0

    Tadeusz Robak, MD, PhD, of the Medical University of Lodz, Lodz, Poland, provides us with an update on the RESONATE-2…

    Tweet Tweets with this article
    • Tadeusz Robak of @umedlodz updates on the RESONATE-2 trial which compared the safety and efficacy of ibrutinib and chlorambucil as a first-line treatment in chronic lymphocytic #Leukemia. 👉Watch here: https://t.co/DUaKbaEoHu @iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc #TrialUpdate

  • Mashup Score: 1

    Kerry Rogers, MD, The Ohio State University, Columbus, OH, discusses the management of autoimmune cytopenia in patients with chronic lymphocytic…

    Tweet Tweets with this article
    • Kerry Rogers of @OhioState discusses the management of autoimmune cytopenia in chronic lymphocytic #Leukemia, highlighting BTK- and PI3K-inhibitors. ▶️Watch here: https://t.co/7p8ucfe0mR @iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc

  • Mashup Score: 1

    Arnon Kater, MD, PhD, University of Amsterdam, Amsterdam, Netherlands, shares his views on current prediction and prognostication methods for the…

    Tweet Tweets with this article
    • Arnon Kater (@UvA_Amsterdam) shares his views on current prediction and prognostication methods for the management of #CLL: https://t.co/btRCDSqG6r @iwCLL #iwCLL2021 #CLLsm #LEUsm #Leukemia #HemOnc